National Access Cannabis (CVE:NAC) insider Matthew Ryan acquired 15,000 shares of the business’s stock in a transaction dated Tuesday, March 20th. The shares were purchased at an average price of C$1.03 per share, with a total value of C$15,450.00.
National Access Cannabis stock opened at C$1.00 on Friday. National Access Cannabis has a 12-month low of C$0.10 and a 12-month high of C$1.20.
National Access Cannabis Company Profile
National Access Clinic Corp., through its subsidiary National Access Canada Corporation, owns and operates clinics in Canada. It provides cannabinoid educational services; and medical cannabis treatments for patients through a network of physicians and health professionals. The company was formerly known as National Access Cannabis Corp.
Receive News & Ratings for National Access Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Access Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.